Moderator note: Great discussion, everyone. Just a reminder to keep things civil and evidence-based.
Thread quality is excellent — keep it up. 👍
Slightly tangential to Cost-effectiveness but SarahChen_PharmD reminded me — has the insurance landscape changed recently?
I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.
CanadaChris said:Follow-up question: what labs did your doctor order to monitor this
This is exactly right. CanadaChris articulated what I have been trying to explain to my friends for months. The Cost-effectiveness aspect is what made the difference for me.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsSaving this for reference. Quality thread.
Adding my data to this Cost-effectiveness discussion:
| Metric | Baseline | Month 3 | Month 6 |
|---|---|---|---|
| Weight | 252 lbs | 222 lbs | 207 lbs |
| A1C | 6.6% | 5.8% | 5.2% |
| hsCRP | 6.0 | 2.0 | 1.0 |
Protocol: Semaglutide 2.4mg/wk, resistance training 3x/wk, protein 1.4g/kg/day.